The novel selective antibody sibeprenlimab reduced proteinuria more than any prior drug for IgA nephropathy, with excellent ...

A subanalysis of the NeflgArd study shows benefits in eGFR and urine protein-creatinine ratio at baseline and across ...

A second-generation anti-CD40 therapy that inhibits B- and T-cell activity nearly eliminated multiple sclerosis activity over ...

A post-hoc analysis of the pivotal CANVAS trial shows those receiving higher dose canagliflozin are more likely to experience the cardiovascular benefits associated with the drug.

MRI visibility and the presence of secondary Gleason pattern 4 at baseline are associated with progression to treatment and ...

But new research published in JAMA Pediatrics found distinct patterns of long COVID symptoms in young children. Researchers ...

Cardiovascular disease and mental illness commonly co-occur. Addressing them together can improve both mental health and ...

Trastuzumab deruxtecan plus pertuzumab outperformed standard-of-care therapy as first-line treatment for HER2-positive ...

A consensus statement from the Society for Perioperative Assessment and Quality Improvement recommends patients should ...

Wastewater monitoring helps communities spot rising outbreaks of influenza, COVID, RSV, and more. Our writer gets her feet ...

A new analysis of Medicare reimbursement for GI procedures shows that physicians lost ground while hospitals and ambulatory ...

Low-dose methotrexate for 1 year does not reduce knee pain or effusion-synovitis in patients with inflammatory knee ...